OncoSil Medical LtdASX: OSL

Oncosil Medical Share Purchase Plan

· Issued by OncoSil Medical Ltd

Filed with ASX · · 26 pages · English

Sydney, Australia, 28 March 2018: OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) a medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to offer eligible Oncosil Medical shareholders the opportunity to participate in the Oncosil Medical Share Purchase Plan (SPP), as announced on 21 March 2018. A booklet containing det

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases